Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

5.1%

5 terminated/withdrawn out of 99 trials

Success Rate

79.2%

-7.3% vs industry average

Late-Stage Pipeline

20%

20 trials in Phase 3/4

Results Transparency

5%

1 of 19 completed trials have results

Key Signals

11 recruiting1 with results

Enrollment Performance

Analytics

N/A
30(43.5%)
Phase 2
16(23.2%)
Phase 3
11(15.9%)
Phase 4
9(13.0%)
Phase 1
3(4.3%)
69Total
N/A(30)
Phase 2(16)
Phase 3(11)
Phase 4(9)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (99)

Showing 20 of 99 trials
NCT07381946Not ApplicableActive Not Recruiting

High-frequency Repetitive Transcranial Magnetic Stimulation for Patients With Dysphagia After Extubation

Role: lead

NCT06975501Not ApplicableActive Not Recruiting

Community-Empowerment and Environmental Enrichment-based Co-management (CEEEC) Model and Mechanisms for Improving Health of Older Stroke Patients With Multimorbidity

Role: collaborator

NCT06971705Not ApplicableActive Not Recruiting

fMRI Study on Cerebral Localization and Network Mechanisms of rTMS in Chronic Ankle Instability Treatment

Role: lead

NCT07085533Recruiting

Natural History Study of Inherited Retinal Diseases

Role: collaborator

NCT06783933Active Not Recruiting

Artificial Intelligence-assisted Diagnosis

Role: collaborator

NCT06532994Recruiting

Predictive Algorithms for Critical Rehabilitation Outcomes

Role: lead

NCT06871826Phase 1Completed

Tissue Inhibitor of Metalloproteinases 2 Level in Patients Undergoing Cardiac Surgery

Role: lead

NCT04212598Phase 2Completed

The Value of Sintilimab Consolidation Therapy After Definitive Concurrent Chemoradiotherapy for Locally Advanced Thoracic Esophageal Cancer

Role: lead

NCT06496919Not Yet Recruiting

A Real-world Research on the Prevention and Treatment of Peritoneal Metastasis and Malignant Ascites by Intraperitoneal Infusion of rmhTNF in Gastric and Colorectal Malignant Tumors

Role: lead

NCT06470178Not Yet Recruiting

A Real-World Study of Neoadjuvant/Conversion Therapy for Colorectal Cancer With Chemotherapy And Anti-Angiogenic Targeted Agents

Role: lead

NCT06464601Not Yet Recruiting

A Real-World Study of Neoadjuvant/Conversion Therapy for Locally Advanced or Metastatic Gastric Cancer

Role: lead

NCT06187597Phase 2Recruiting

Consolidation of Toripalimab After Chemoradiotherapy in Elderly Esophageal Cancer (EC-CRT-007)

Role: collaborator

NCT04923802Terminated

Multi-Omics Testing for Immunotherapy Efficacy Evaluation (MOTIVATION)

Role: collaborator

NCT03895593Recruiting

Rescue Fecal Microbiota Transplantation for National Refractory Intestinal Infections

Role: collaborator

NCT06236022Phase 4Recruiting

The Effects of Sirolimus in Patients With Dilated Cardiomyopathy Infected With Kaposi Sarcoma-associated Virus

Role: collaborator

NCT04397211Not ApplicableActive Not Recruiting

Angiography-Derived FFR And IVUS for Clinical Outcomes in Patients With Coronary Artery Disease

Role: collaborator

NCT06009991Not ApplicableUnknown

The Dose Range of Remimazolam Besylate in Different Age Groups

Role: collaborator

NCT04063956Not ApplicableUnknown

COG-REAGENT: COGnitive tRaining in patiEnts With Amnestic Mild coGnitive impairmENT

Role: collaborator

NCT05841082Unknown

Coronary Revascularization in Patients On Dialysis in China-Retrospective Registry

Role: collaborator

NCT03802058Phase 2Terminated

Concurrent Nab-P/Carboplatin and Thoracic Radiotherapy in Squamous Cell Lung Cancer

Role: lead